Good news for CA providers and residents! Starting July 1, 2024, Pharmacogenomic (PGx) biomarker testing will be a covered benefit for all Californians*, regardless of insurance provider. PGx testing is already a covered benefit for Medicare patients. Read the press release below, and learn more on the American Cancer Society’s Cancer Action Network website. Read the legislation here. *For insured … Read More